Comparative activities of LY 164846 and other orally administered beta-lactam antibiotics against Haemophilus influenzae | Zendy

J. H. Jorgensen | Zendy; J S Redding | Zendy; A W Howell | Zendy

Open Access

Comparative activities of LY 164846 and other orally administered beta-lactam antibiotics against Haemophilus influenzae

Author(s) -

J. H. Jorgensen,

J S Redding,

A W Howell

Publication year - 1986

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.29.6.1090

Subject(s) - cefaclor , haemophilus influenzae , cephalosporin , amoxicillin , microbiology and biotechnology , antibiotics , antibacterial agent , clavulanic acid , beta lactamase , minimum inhibitory concentration , chemistry , medicine , biology , escherichia coli , biochemistry , gene

LY 164846, a new oral cephalosporin, demonstrated very good inhibitory and bactericidal activities against Haemophilus influenzae irrespective of the production of beta-lactamase by the test strains. However, its activity was not markedly superior to that of either Augmentin (amoxicillin plus clavulanate) or cefaclor.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research